Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyrrole SCHEMBL27352233 | 0.97 | ALDH1A1 (0.47) | ALDH1A1 | |
| Pyrrole SCHEMBL28200279 | 0.94 | ALDH1A1 (0.44) | ALDH1A1 | |
| Dioxane SCHEMBL28087350 | 0.87 | TTR (0.43) | ALDH1A1 | |
| Pyrrole SCHEMBL18339868 | 0.83 | — | — | |
| Pyrrole SCHEMBL29867603 | 0.80 | — | — | |
| Morpholine SCHEMBL9049013 | 0.77 | MEN1 (0.58) | — | |
| Benzene SCHEMBL1051803 | 0.75 | ALDH1A1 (0.73) | ALDH1A1 | |
| Cycloheptane SCHEMBL31385525 | 0.75 | — | — | |
| Pyrrole SCHEMBL10930986 | 0.75 | — | — | |
| Cyclohexane SCHEMBL28349733 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248651-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-08-10 | — | — | US | disclosed |
| US-11642313-B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-05-09 | — | — | US | disclosed |
| US-20210059940-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2021-03-04 | — | — | US | disclosed |
| US-10842748-B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2020-11-24 | — | — | US | disclosed |
| US-20200078301-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2020-03-12 | — | — | US | disclosed |
| CN-109836822-A | A kind of soluble conductive polypyrrole and preparation method thereof that poly ion liquid is modified | 东华大学 | 2019-06-04 | — | — | CN | disclosed |
| CN-109810250-A | A kind of preparation method of soluble conductive polypyrrole | 东华大学 | 2019-05-28 | — | — | CN | disclosed |
| EP-2534151-B1 | 8-METHYL-1-PHENYL-IMIDAZOL[1,5-A]PYRAZINE COMPOUNDS | MERCK SHARP & DOHME (NL) | 2018-11-14 | — | — | EP | disclosed |
| US-20180116959-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | NATIONAL SCIENCE FOUNDATION | 2018-05-03 | — | — | US | disclosed |
| CN-107849023-A | Bicyclic lactams and methods of use thereof | 豪夫迈·罗氏有限公司 | 2018-03-27 | — | — | CN | disclosed |
| WO-1995030638-A1 | PROCESS FOR PREPARING INTERMEDIATES FOR THE SYNTHESIS OF ANTIFUNGAL AGENTS | SCHERING CORPORATION (US) | 1995-11-16 | — | — | WO | disclosed |
| US-5442093-A | Heating mixture of difluorobenzene derivative, allene, dialkyl malonate, base in polar organic solvent with catalyst in sealed vessel at specified pressure | SCHERING CORPORATION (US) | 1995-08-15 | — | — | US | disclosed |
| WO-1995016658-A1 | PROCESS FOR PREPARING INTERMEDIATES FOR THE SYNTHESIS OF ANTIFUNGAL AGENTS | SCHERING CORPORATION (US) | 1995-06-22 | — | — | WO | disclosed |
| WO-1995016658-A1 | PROCESS FOR PREPARING INTERMEDIATES FOR THE SYNTHESIS OF ANTIFUNGAL AGENTS | SCHERING CORPORATION (US) | 1995-06-22 | — | — | WO | disclosed |
| US-5403937-A | Process for preparing intermediates for the synthesis of antifungal agents | SCHERING CORPORATION (US) | 1995-04-04 | — | — | US | disclosed |
| US-5403937-A | Process for preparing intermediates for the synthesis of antifungal agents | SCHERING CORPORATION (US) | 1995-04-04 | — | — | US | disclosed |
| WO-1994025452-A1 | PROCESS FOR PREPARING INTERMEDIATES FOR THE SYNTHESIS OF ANTIFUNGAL AGENTS | SCHERING CORPORATION (US) | 1994-11-10 | — | — | WO | disclosed |
| WO-1994025452-A1 | PROCESS FOR PREPARING INTERMEDIATES FOR THE SYNTHESIS OF ANTIFUNGAL AGENTS | SCHERING CORPORATION (US) | 1994-11-10 | — | — | WO | disclosed |
| US-5349099-A | Process for preparing intermediates for the synthesis of antifungal agents | SCHERING CORPORATION (US) | 1994-09-20 | — | — | US | disclosed |
| US-5349099-A | Process for preparing intermediates for the synthesis of antifungal agents | SCHERING CORPORATION (US) | 1994-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11642313-B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | PFN1, FLNA, FSCN1 | ALDH1A1 3501/4885 |
| US-20210059940-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | PFN1, FLNA, FSCN1 | ALDH1A1 3501/4885 |
| US-10842748-B2 | Methods for fabricating isolated micro- or nano-structures using soft or imprint lithography | PFN1, FLNA, FSCN1 | ALDH1A1 3501/4885 |
| US-20200078301-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | PFN1, FLNA, FSCN1 | ALDH1A1 3501/4885 |
| US-20180116959-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | PFN1, FLNA, FSCN1 | ALDH1A1 3501/4885 |
| US-20230248651-A1 | METHODS FOR FABRICATING ISOLATED MICRO- OR NANO-STRUCTURES USING SOFT OR IMPRINT LITHOGRAPHY | PFN1, FLNA, FSCN1 | ALDH1A1 3501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.